切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2020, Vol. 13 ›› Issue (04) : 551 -554. doi: 10.3877/cma.j.issn.1674-6902.2020.04.031

综述

特发性肺纤维化与胃食道返流研究进展
陈宇平1, 朱毅2,()   
  1. 1. 215000 江苏,盛泽医院呼吸内科
    2. 210029 江苏,南京医科大学第一附属医院呼吸内科
  • 收稿日期:2020-01-21 出版日期:2020-08-25
  • 通信作者: 朱毅

Progress of idiopathic pulmonary fibrosis and gastroesophageal reflux

Yuping Chen1, Yi Zhu2()   

  • Received:2020-01-21 Published:2020-08-25
  • Corresponding author: Yi Zhu
引用本文:

陈宇平, 朱毅. 特发性肺纤维化与胃食道返流研究进展[J]. 中华肺部疾病杂志(电子版), 2020, 13(04): 551-554.

Yuping Chen, Yi Zhu. Progress of idiopathic pulmonary fibrosis and gastroesophageal reflux[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2020, 13(04): 551-554.

1
崔社怀. 特发性肺间质纤维化的回顾和展望[J/CD]. 中华肺部疾病杂志(电子版), 2010, 3(1): 4-5.
2
任成山. 特发性间质性肺炎的现代概念及研究进展[J/CD]. 中华肺部疾病杂志(电子版), 2010, 3(4): 276-284.
3
Martinez-Ramirez D, Almeida L, Giugni JC, et al. Rate of aspiration pneumonia in hospitalized Parkinson′s disease patients: a cross-sectional study[J]. BMC Neurol, 2015, 15(1): 104.
4
Kwon HY, Lim JH, Shin YW, et al. A Case of Chronic Cough Caused by Achalasia Misconceived as Gastroesophageal Reflux Disease[J]. Allergy Asthma Immunol Res, 2014, 6(6): 573-576.
5
Ahrens P, Weimer B, Hofmann D. Severe interstitial lung disease from pathologic gastroesophageal reflux in children[J]. Pneumologie,1999, 53(7): 369-372.
6
Ayala P, Torres J, Vivar R, et al. Acute lung injury by gastric fluid instillation: activation of myofibroblast apoptosis during injury resolution[J]. Respir Res, 2018, 19: 57.
7
Liu JR, Xu XF, Zhou CJ, et al. Bronchiolitis Obliterans Organizing Pneumonia Due to Gastroesophageal Reflux[J]. Pediatrics, 2015, 135(6): e1510-e1513.
8
Ozaydin I, Annakkaya AN, Ozaydin C, et al. Effects of cruroraphy and laparoscopic Nissen fundoplication procedures on pulmonary function tests in gastroesophageal reflux patients[J]. Int J Clin Exp Med, 2014, 7(2): 431-434.
9
Savarino E, Carbone R, Marabotto E, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients[J]. Eur Respir J, 2013, 42(5): 1322-1331.
10
Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid reflux in idiopathic pulmonary fibrosis[J]. Eur Respir J, 2006, 27(1): 136-142.
11
Lee CM, Lee DH, Ahn BK, et al. Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis[J]. J Neurogastroenterol Motil, 2016, 22(3): 444-451.
12
Allaix ME, Fisichella PM, Noth I, et al. Idiopathic Pulmonary Fibrosis and Gastroesophageal Reflux. Implications for Treatment[J]. J Gastrointest Surg, 2014, 18(1): 100-105.
13
Lee JS, Collard HR, Raghu G, et al. Does chronic microaspiration cause idiopathic pulmonary fibrosis? [J]. Am J Med, 2010, 123(4): 304-311.
14
Sweet MP, Patti MG, Leard LE, et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation[J]. J Thorac Cardiovasc Surg 2007, 133(4): 1078-1084.
15
Tcherakian C, Cottin V, Brillet PY, et al. Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease[J]. Thorax, 2011, 66(3): 226-231.
16
Savarino E, Carbone R, Marabotto E, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients[J]. Eur Respir J, 2013, 42: 1322-1331.
17
Gavini S, Borges LF, Finn RT, et al. Lung disease severity in idiopathic pulmonary fibrosis is more strongly associated with impedance measures of bolus reflux than pH parameters of acid reflux alone[J]. Neurogastroenterol Motil, 2017, 29: e13001.
18
Lee JS, Song JW, Wolters PJ, et al. Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis[J]. Eur Respir J, 2012, 39: 352-358.
19
Bobadilla JL, Jankowska-Gan E, Xu Q, et al. Reflux-Induced Collagen Type V Sensitization Potential Mediator of Bronchiolitis Obliterans Syndrome[J]. Chest, 2010, 138(2): 363-370.
20
D′Ovidio F, Mura M, Ridsdale R, et al. The effect of reflux and bile acid aspiration on lung allograft and its surfactant and innate immunity molecules SP-A and SP-D[J]. Am J Transplant, 2006, 6(8): 1930-1938.
21
Lee JS, Collard HR, Anstrom KJ, et al. Anti-Acid Therapy and Disease Progression in Idiopathic Pulmonary Fibrosis: an analysis of data from three randomized controlled trials[J]. Lancet Respir Med, 2013, 1(5): 369-376.
22
Lee JS, Ryu JH, Elicker BM, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2011, 184(12): 1390-1394.
23
Raghu G, Yang ST, Spada C, et al. Sole treatment of acid gastroesophageal reflux in idiopathic pulmonary fibrosis: a case series[J]. Chest, 2006, 129(3): 794-800.
24
Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications[J]. Dig Dis Sci, 2009, 54(11): 2312-2317.
25
Ghebremariam YT, Cooke JP, Gerhart W, et al. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis[J]. J Transl Med, 2015, 13: 249.
26
Kreuter M, Wuyts W, Renzoni E, et al. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis[J]. Lancet Respir Med, 2016, 4(5): 381-389.
27
Tobin RW, Pope CE, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis[J]. Am J Resp Crit Care Med, 1998, 158(6): 1804-1808.
28
Kauer WK, Peters JH, DeMeester TR, et al. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone[J]. Ann Surg,1995, 222(4): 525-531.
29
Kilduff CE, Counter MJ, Thomas GA, et al. Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study[J]. Cough, 2014, 10: 4. doi: 10.1186/1745-9974-10-4.
30
Chen B, Cai HR, Xue S, et al. Bile acids induce activation of alveolar epithelial cells and lung fibroblasts through farnesoid X receptor-dependent and independent pathways[J]. Respirology, 2016, 21(6): 1075-1082.
31
Chen B, You WJ, Liu XQ, et al. Chronic microaspiration of bile acids induces lung fibrosis through multiple mechanisms in rats[J]. Clin Sci (Lond), 2017, 31(10): 951-963.
32
Borges LF, Jagadeesan V, Goldberg H, et al. Abnormal Bolus Reflux Is Associated With Poor Pulmonary Outcome in Patients With Idiopathic Pulmonary Fibrosis[J]. J Neurogastroenterol Motil, 2018, 24(3): 395-402.
33
Linden PA, Gilbert RJ, Yeap BY, et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation[J]. J Thorac Cardiovasc Surg, 2006, 131(2): 438-446.
34
Raghu G, Pellegrini CA, Yow E, et al. Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial[J]. Lancet Respir Med, 2018, 6(9): 707-714.
35
Griffin SM, Robertson AG, Bredenoord AJ, et al. Aspiration and allograft injury secondary to gastroesophageal reflux occur in the immediate post-lung transplantation period (prospective clinical trial)[J]. Ann Surg, 2013, 258(5): 705-711.
36
Blondeau K, Mertens V, Vanaudenaerde BA, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection[J]. Eur Respir J, 2008, 31: 707-713.
37
D′Ovidio F, Mura M, Tsang M, et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation[J]. J Thorac Cardiovasc Surg, 2005, 129: 1144-1152.
38
Fisichella PM, Davis CS, Lundberg PW, et al. The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation[J]. Surgery, 2011, 150: 598-606.
39
Davis RD, Lau CL, Eubanks S, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation[J]. J Thorac Cardiovasc Surg, 2003, 125: 533-542.
40
Lo WK, Goldberg HJ, Wee J, et al. Both Pre-Transplant and Early Post-Transplant Antireflux Surgery Prevent Development of Early Allograft Injury After Lung Transplantation[J]. J Gastrointest Surg, 2016, 20(1): 111-118.
[1] 周璇, 谢莉, 邹娟. 尼达尼布对特发性肺纤维化肺功能、肺纤维化程度及PDGF、PGE2、TGF-β1的影响[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 368-372.
[2] 邱凌霄, 王创业, 卿斌, 刘锦程, 张鑫烨, 武文娟, 邢德冰, 郭亮, 徐智, 王斌. 基于转录组学筛选特发性肺纤维化的枢纽基因和信号通路[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 212-217.
[3] 吴沛玲, 娄月妍, 张洪艳, 陈东方, 刘雪青, 赵丽芳, 薛姗, 蒋捍东. 线粒体相关基因在特发性肺纤维化中的分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(02): 178-184.
[4] 拉周措毛, 山春玲, 李国蓉, 华毛. 青海西宁地区IPF-LC的病理类型及临床特征分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(01): 25-29.
[5] 谷先勇, 徐娟. 特发性肺纤维化合并T2DM炎症水平与预后相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(05): 721-723.
[6] 杜文峰, 周玲, 李琪. 血清KL-6对特发性肺纤维化患者诊断及预后的意义[J]. 中华肺部疾病杂志(电子版), 2022, 15(02): 218-220.
[7] 刘雪娇, 盛伟利, 丁艳艳, 尹凤先. 特发性肺纤维化急性加重患者预后危险因素及意义[J]. 中华肺部疾病杂志(电子版), 2022, 15(02): 212-214.
[8] 李佳怡, 王亚菲, 郝月琴, 陈建攸. CXCL14、TGF-β1和CTGF水平与特发性肺纤维化的关系[J]. 中华肺部疾病杂志(电子版), 2021, 14(02): 222-224.
[9] 孙莹, 宋晓萍, 孙伟. 探讨TGFβ1、PDGF、VEGF对特发性肺纤维化诊断及病情评估的临床意义[J]. 中华肺部疾病杂志(电子版), 2020, 13(01): 54-58.
[10] 张致苍, 雷尚昆. 血清LTBP2作为特发性肺纤维化患者预后标志物的研究[J]. 中华肺部疾病杂志(电子版), 2019, 12(06): 733-737.
[11] 杨育坤, 李晔, 朱向情, 雷银, 王严影, 田川, 阮光萍, 潘兴华. Ⅱ型肺泡上皮细胞与特发性肺纤维化的关系研究进展[J]. 中华细胞与干细胞杂志(电子版), 2019, 09(05): 304-308.
[12] 吕昆明, 王沙沙, 万军, 令狐恩强. 胃食管反流病与特发性肺纤维化关系的研究进展[J]. 中华胃肠内镜电子杂志, 2023, 10(02): 121-124.
[13] 翟胜爽, 雷小红, 赵子锌, 王鹤, 卢林, 孙琳林. 涎液化糖链抗原-6在老年特发性肺纤维化诊治中的应用[J]. 中华老年病研究电子杂志, 2020, 07(02): 26-31.
[14] 郭娜娜, 刘学军, 杜毓锋, 钱力, 郝小燕, 刘丽芳. 端粒与衰老及特发性肺纤维化的相关性研究[J]. 中华老年病研究电子杂志, 2018, 05(04): 46-48.
[15] 郭娜娜, 刘学军, 杜毓锋, 郝小燕, 钱力. 肺部疾病对肠黏膜屏障影响的研究进展[J]. 中华老年病研究电子杂志, 2018, 05(03): 45-48.
阅读次数
全文


摘要